Saturday, May 25, 2013 Last update: Yesterday, 10:04 PM
Company Tech News as it Breaks
AmpliPhi Biosciences
News articles for AmpliPhi Biosciences:
Monday, February 4, 2013
- AmpliPhi Receives Notice of Allowance on Key Patent for its Bacteriophage Therapy to Treat Drug-resistant Biofilm-based InfectionsAmpliPhi Biosciences Corporation [APHB.PK] (“Ampliphi”)(OTCBB:APHB), the anti-infective company focused on developing phage-based therapies to combat the growing threat of antibiotic-resistant infection, today ... read more